Inventisbio Co., Ltd
Clinical trials sponsored by Inventisbio Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Liver function may change how D-2570 works in the body Results expected Oct 2026 (estimated)
- Kidney function may change how D-2570 works in the body Results expected Nov 2026 (estimated)
- New pill could offer hope for advanced breast cancer patients Results expected Nov 2026 (estimated)
- New pill could tame tough psoriasis without injections Results expected Jul 2027 (estimated)
- New psoriasis pill shows promise in major trial Results expected Jul 2027 (estimated)
-
A pill aimed at Hard-to-Treat cancers: scientists test YF087 in tumors with broken DNA repair
Disease control Not yet recruitingResearchers are testing an experimental daily pill called YF087 in adults with advanced solid tumors that have a genetic feature called MSI-H or dMMR. These tumors often stop responding to standard immunotherapy, so new options are needed. The phase 1 trial aims to find a safe do…
Phase 1 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Kidney function may change how D-2570 works in the body
Knowledge-focused Not yet recruitingThis study looks at how the drug D-2570 moves through the body in people with reduced kidney function compared to those with normal kidneys. About 40 adults aged 18 to 70 will receive a single dose of D-2570. Researchers will measure drug levels in the blood and monitor for side …
Phase 1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC